Description: 2021 Life Meeting - Session 8E: Insurance M&A Valuation Methodologies and Considerations 9.1.21 Recording

Description: The COVID-19 pandemic has had an impact on all aspects of daily life and its impact extends to how disability incidence may play out in the future. Product profitability will be shaped by how morbidity patterns, interest rate levels and other key drivers will play out into the future. In this session, our panel will discuss COVID’s impact on IDI morbidity experience as observed over the past 18 months, offer comparisons and insights in light of other insurance lines of business, and share emerging information on the on-going effects of Long COVID. Highlights will also include how regional differences and implications for insurers as the industry moves further into the COVID vaccine era.

Description: 2021 Life Meeting - Session 9D: MRBs: Special Considerations for Fixed Indexed Annuities 9.1.21 Recording

Description: Accounting Standards; Valuation Actuary

Description: While a rising sea helps all ships, the insurance industry is a ship that hasn't seen much water in the past decade. Examine valuation and product management considerations in a high interest rate environment

Description: Join this discussion on Valuation topics from both a GAAP and Statutory basis with a spin on how to communicate them to a non-Actuarial and leadership audience. It will include, but certainly not limited to, discussion on IBNR analysis, PAD and its purpose, Wallstreet metrics such as Days in Claims Payable and Medical Claims Payable Growth vs Premium and Membership Growth. The key here is to not only educate on the Valuation processes and metrics, but also to show the best ways to communicate them so that a less technical audience can interpret the impact and make better strategic decisions. It is also to show the importance of the Valuation reserves on the balance sheet and income statements in regards to a Public company and how WallStreet interprets the numbers.

Description: The topics of ESG (Environmental, Social & Corporate Governance) and sustainability are an increasing area of focus for insurance companies, and thus actuaries. This webcast provides a primer on these topics along with considerations for US valuation actuaries and their evolution in European insurance markets.

Description: Explore the role of inflation across health products, including medical plans, disability, and long-term care. Explore various drivers of cost trends, wage increase, and cost of care. Understand their role in the pricing and valuation of a product and how to manage the risk.

Description: If you're intrigued by the impact of recent interest changes or updates about the Principle Based Reserves ASOP 22 Statements of Actuarial Opinions Based on Asset Adequacy Analysis for Life Insurance, Annuity or Health Insurance Reserves and Other Liabilities, then this webcast discussion featuring three expert speakers will grab your attention. Join us for the annual Year-End U.S. Statutory Financial Reporting Considerations webcast and discover more about cash flow testing, as well as potential changes to statutory financial reporting due to climate change. This popular webcast will be taking place December 14, so don't miss out on the latest considerations from our important speakers.

Description: Hot Topics in Setting Pension Return Assumptions is the third in a series, following Mathematics of Pension Return Assumption and Inflation, focusing on Effects, Forecasts, and Role in Pension Valuations. What time horizon is more appropriate for Capital Market Assumption (CMA) forecasts: mid-term or long-term time horizon, or a blend of both? How do we map the asset classes of a plan's own investment policy to the asset classes of investment forecasters' CMAs? If we use asset-smoothing for valuation assets, should we use market-driven expected returns or smoothed/average versions of them?